SOM Biotech at European Conference on Recent Advances in Lysosomal Diseases

posted on November 4, 2019
Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK. The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the lysosomal storage in the cells,…
continue reading →

SOM Biotech at Bio-Europe 2019

posted on October 24, 2019
SOM Biotech will participate in the 25th Annual International Partnering Conference “Bio-Europe” on November 10th -13th- in Hamburg, Germany. The conference, Europe´s largest life science partnering venue, is one of the most relevant events to meet with world-leading life science partners, investors, and industry experts. Raul Insa – CEO of SOM Biotech – and Maria…
continue reading →

SOM Biotech at the 19th Annual Schrödinger European User Group Meeting

posted on October 22, 2019
Luca Signorile, the Senior Computational Chemist at SOM Biotech, participated in the 19th Annual Schrödinger European User Group Meeting, that took place in Berlin on September 25th-27th. The Meeting aimed at illustrating how the capabilities of the Schrödinger software can be efficiently applied to drug discovery to increase research productivity. Science and Technology are the…
continue reading →

Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson’s Research

posted on October 18, 2019
 Dr. Joaquim Trias, Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson's Research, last October 13th Sunday in San Mateo. The run was organized by The Michel J. Fox Foundation, a prestigious organization launched in year 2000 by the iconic actor Michael J.…
continue reading →

SOM Biotech aims to strengthen its communication and investor relations strategy with the support of Maqua Capital

posted on July 24, 2019
As an essential part of SOM  Biotech´s strategy to strengthen its visibility within the investment community and with all its stakeholders, the company has hired the services of Maqua Capital, a consulting firm specialized in Investor Relations and Financial Communication. Maqua Capital will design and implement a strategic corporate communication and investor relations plan to…
continue reading →

SOM Biotech attended 3rd “Hard Reg Café” meeting dedicated to the topic of FDA approval for new drugs

posted on July 23, 2019
Dr. Maria Zimina, Business Development Manager at SOM Biotech, attended “Hard Reg Café” of Regulatory Affairs meeting that took place on June 5 at the Barcelona Science Park (www.pcb.ub.edu). The event was organized by the CataloniaBio & HealthTech Regulatory Affairs Workgroup with the support of ACCIÓ (Government of Catalonia). The main objective of the meeting…
continue reading →